Loading clinical trials...
Loading clinical trials...
Safety and Feasibility of Akkermansia Probiotics Combined With Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer
Conditions
Interventions
Akkermansia Probiotics
Locations
2
China
Colorectal Cancer, West China Hospital
Chengdu, Sichuan, China
Colorectal Cancer, West China Hospital
Chengdu, Sichuan, China
Start Date
February 21, 2025
Primary Completion Date
July 10, 2025
Completion Date
March 22, 2027
Last Updated
April 13, 2026
NCT07239661
NCT07233252
NCT07148297
NCT07126119
NCT06332274
NCT04291105
Lead Sponsor
West China Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions